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2 K. Uematsu et al.However, these expanded periosteal sheets exhibited substantially stronger osteogenic differentiation when implanted in nude
mice. Therefore, despite our reservations, MesenPRO medium effectively expanded the cells contained in periosteal sheets to
promote the formation of thicker multilayers of cells in vitro, and these enhanced periosteal sheets expressed increased
osteogenic potential at implantation sites in vivo. In conjunction with data indicating that CD146-positive cells were notably
expanded and the recently proposed concept that CD146 is a marker for osteogenic progenitor cells found in the bone marrow
stroma, our findings suggest that MesenPRO medium improves the preparation of highly osteogenic periosteal sheets suitable
for clinical application largely through the induction of CD146-positive cells.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.Introduction
The periosteum has recently been recognized as a promising
source of immature progenitor cells that are not yet com-
mitted to specific cell lineages and osteogenic progenitors.
For osteogenic cell processing in tissue engineering, the
periosteum has generally been utilized to prepare dispersed
cells (Hutmacher and Sittinger, 2003). The initial advantage of
this conventional method is that periosteal sheet-derived cells
grow faster in dispersed, single cell cultures than in explant
cultures. However, one crucial disadvantage is the frequent
contamination by non-progenitor cells, such as fibroblastic
cells that often inhibit the differentiation of the progenitor
cells in vitro (Iwasaki et al., 1995; Solchaga et al., 1998). The
second advantage of this expansion culture is that the
fibroblastic contamination can be easily removed by cell
fractionation based on cell-surface antigens.
Compared with this popular cell-dispersion method, an
alternate method that uses explant culture from harvested
periosteal tissue segments, which we have followed in our
clinical practice, may be perceived to increase the risk of
fibroblastic contamination and lengthen the processing
time. Due to the limitations of permitted human surgeries,
it is difficult to harvest an intact cambium layer, the lower
osteoblastic-cell layer of the periosteum, from human
alveolar bone tissues in routine clinical practice (Kawase,
2010). Therefore, taken together with the inability to
perform cell fractionations, it would appear unlikely that
this methodology could successfully transfer sufficient
numbers of osteoblastic cells to the culture condition.
However, we believe the cellular multilayered tissue-like
periosteal sheets prepared by explant culture are substantial-
ly superior to the monolayer formed from dispersed periosteal
sheet-derived cells because the multilayered periosteal
sheets possess a tougher mechanical property than the
mono-layered periosteal cells and are more amenable to
handling. These are attractive features for any grafting
material. In addition, this methodology also has the advantage
of minimizing manipulation so that the risk of possible cell
damage or transformation is reduced. In previous basic studies
(Kawase et al., 2009, 2010a), we demonstrated that when
cultured periosteal sheets are subcutaneously implanted into
nude mice, their original periosteum tissue segments function
as nuclei of mineralization to promote the formation of
bone-like tissue. Furthermore, in previous clinical studies
(Yamamiya et al., 2008; Okuda et al., 2009; Nagata et al.,
2012), we demonstrated the successful regeneration of
alveolar bone using this periosteal-sheet preparation in
periodontal regenerative therapy.Although pre-osteoblastic or more mature osteoblastic
cells can be harvested for culture, these cells are generally
slow to grow and difficult to expand in vitro. In contrast, we
have recently found in our prepared periosteal sheets a
group of highly proliferative cells that reside around
capillary blood vessels contained within the region of the
original periosteal segment (Kawase, 2010; Kawase et al., in
press). We speculate that these cells could be immature
progenitor cells that are either not yet committed to a
specific lineage or constitute somewhat immature osteo-
genic progenitor cells when derived from bone-related
tissues. Relevant to this point, we have been able to
generate cells of osteoblast lineage by treating periosteal
sheets with conventional commercial methods of osteogenic
induction, so we know that immature osteogenic cells are
present. If this is the case, then it is possible that culture
media developed and formulated to maintain or expand
stem cells would be useful for the expansion of these
immature progenitor cells. In this manner, the combination of
a specific medium and our developed culture protocol should
function as a promising cell-expansion system to improve the
effectiveness and clinical utility of cultured periosteal sheets
when used as osteogenic grafting materials.
To test this hypothesis and to develop a more potent
version of our grafting material, we have screened several
commercially available culture media (each advertised as a
“stem-cell culture medium”) in the periosteal-sheet culture
system. Among them, MesenPRO medium showed the highest
capability for securing periosteal sheets onto the plastic
culture ware in the presence of 2% (v/v) fetal bovine serum
(FBS). We have examined the effects of MesenPRO on the
maintenance or expansion of immature progenitor cells in
periosteal sheets, and demonstrated how it affected the
osteogenic potential expressed by the multilayer of cells
upon implantation into nude mice.Materials and methods
Isolation and culture of human periosteal sheets
With informed consent, human periosteum tissue segments
were aseptically dissected from the periodontal tissues of the
healthy buccal side of the retromolar region of the mandible of
nonsmoking volunteers (Kawase et al., 2009). Small pieces
(2×2 mm) were placed on plastic multi-well plates, glass
coverslips, or atelocollagen mesh made of bovine epidermis
(Integran®; Koken, Tokyo, Japan) and subjected to explant
culture in humidified 5% CO2, 95% air at 37 °C with either
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bovine serum (FBS) (Invitrogen), 25 μg/mL ascorbic acid
2-phosphate, and antibiotics (control medium), or MesenPRO-
RS™ (Invitrogen) supplemented with 2% FBS, 25 μg/mL
ascorbic acid 2-phosphate, and antibiotics. For osteogenic
induction, human periosteal sheets were treated with 3%
KE-200, a commercial osteogenic-inducing agent (DS Pharma,
Osaka, Japan) that contains, at a minimum, dexamethasone,
β-glycerophosphate, and L-ascorbic acid (Kawase et al.,
2009).
All subjects enrolled in this study have positively
responded to an Informed Consent that was approved on
June 22, 2006 by the Ethics committee for human subject
use at Niigata University Medical and Dental Hospital in
accordance with the Helsinki Declaration of 1975 and as
revised in 2008.
Optical analysis of the periosteal sheet's thickness
by near-infrared (NIR) imaging
Cyclic- RGD peptide (amino acid sequence of arginine–
glycine–aspartic acid) conjugated with a NIR dye (IRDye®
800CW; excitation/emission, 774/789 nm) was obtained
from LI-COR Bioscience (Lincoln, NE, USA). This probe was
demonstrated to be a specific ligand for the integrin
receptor αvβ3, vitronectin receptor (Kovar et al., 2007).
Periosteal sheets were rinsed three times with Medium 199
containing 1% FBS and 10 mM Hepes (Invitrogen), and then
incubated with 20 nM IRDye® 800CW-RGD probe in the
HEPES-buffered medium for 3 h at 4 °C. As described
previously (Nakayama et al., 2011a), in vitro NIR imaging
was performed using Pearl® Imager (LI-COR Bioscience)
with excitation/emission wave lengths fixed at 785/820 nm,
without fixing the periosteal sheets. Fluorescence signal was
detected by a cooled CCD camera from the Pearl Imager and
was represented by pixel density. For the image analysis,
as described previously (Nakayama et al., 2011a), circles
covering periosteal sheets were drawn as regions of interest
(ROIs) in individual images and the pixel density in the
selected ROIs was quantitated using software provided with
the Pearl Imager. After subtracting the background levels, the
data were expressed in fluorescence intensity (FI) in the result
section.
Histological and immunohistochemical examination
Periosteal sheets cultured on plastic plates were harvested,
fixed, and embedded in paraffin, as described previously
(Kawase et al., 2009; Suzuki et al., 2011). Periosteal sheets
implanted in nude mice were retrieved with surrounding
tissues, fixed, and decalcified with 0.5 M EDTA, prior to
being dehydrated and embedded in paraffin. Periosteal
sheets were serially sectioned sagittally at 6 μm thick and
stained with hematoxylin and eosin (HE), Mason's trichrome
(MT) (Kawase et al., 2012a), Alcian blue, 0.1% Safranin O, or
0.1% Toluidine blue (pH 4.1).
For immunohistochemical and immunofluorescent staining
(Kawase et al., 2011), the sections were subjected to antigen-
retrieval, blocking of endogenous peroxidase, and blocking of
nonspecific binding with 2.5% normal horse serum (Vector
Labs., Burlingame, CA).The sections were probed with the following primary
antibodies diluted with Immuno Shot Mild (Cosmobio, Tokyo,
Japan): mouse monoclonal anti-PCNA (1:100) (Santa Cruz
Biotechnology, Santa Cruz, CA), mouse monoclonal anti-
αSMA (1:100) (Abcam, Cambridge, MA), rabbit polyclonal
anti-collagen type I antibody (1:100) (Abcam), rabbit polyclon-
al anti-collagen type II antibody (1:100) (Abcam), rabbit
polyclonal anti-CD146 (1:300) (Abcam), rabbit polyclonal
anti-ALP (1:50) (Abcam), rabbit polyclonal anti-Runx2 (1:200)
(Bioworld technology, Inc., Minneapolis, MN), rabbit polyclonal
anti-Sox9 (1:100) (Abcam), rabbit polyclonal anti-human
Ki67 antibody (1:1000) (Abcam). The sections were then
probed with the secondary antibody, anti-rabbit IgG
(Invitrogen) diluted with Immuno Shot Mild (Cosmobio,
Tokyo, Japan) or ImmPRESS® anti-mouse IgG (Vector Labs.,
Burlingame, CA) for 30 min at room temperature. Target
proteins were visualized through diaminobenzidine solution
(DAB) (KPL, Inc., Gaithersburg, MD), and the sections were
faintly counterstained by hematoxylin. For the negative
control, a non-immune rabbit IgG (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA) was employed.
Alternatively, the sections probed with the primary
antibodies were probed with Alexa Fluor® 488 (or 546)-
conjugated goat anti-mouse IgG (1:100) or Alexa Fluor® 488-
conjugated goat anti-rabbit IgG (1:100) (Invitrogen) for 30 min
at room temperature. After DNA staining with DAPI (0.5 μg/mL)
(Dojin, Kumamoto, Japan), the sections were examined by a
fluorescence microscope (Nikon, Tokyo, Japan).
Periosteal sheet-derived cells were cultured on coverslips
and fixed, blocked, and directly probed with anti-αSMA
antibody, followed by visualization with Alexa Fluor® 546-
conjugated goat anti-mouse IgG (1:100), and examined as
described above.
Periosteal sheets were fixed and stained by the azo-dye
technique, as described previously (Kawase et al., 2009), to
stain for ALP activity. To visualize whole periosteal sheets
cultured in plates, 1% Safranin O was used to counterstain
the nuclei.
For positive and negative controls, the articular carti-
lage of the femur was excised from a Wister rat (female,
24-weeks-old), decalcified with 0.5 M EDTA (Wako) for
2 weeks, embedded in paraffin, sectioned, and stained as
described above.Determinations of cellular DNA contents and
collagen in culture supernatantsPeriosteal sheets were rinsed twice with PBS, detached
with a cell scraper, and transferred to sample tubes. After
centrifugation, periosteal sheets that were precipitated
were lysed in Cell Lysis Buffer (Invitrogen). The DNA
contents were determined by use of Qubit® dsDNA BR
Assay Kit (Invitrogen).
To determine the contents of the collagen released from
cultured periosteal sheets, Sircol™ soluble collagen assay
kit (Biocolor Ltd., County Antrim, UK), was utilized based
on the principle that Sirius Red in picric acid specifically
binds to collagen. According to the manufacturer's instruc-
tion, the culture supernatants were directly subjected to
the assay.
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II, Runx2, and Sox9
As described previously (Kawase et al., 2005), after removing
the parts of the original periosteum segments, the rest of
periosteal sheets were lysed in Laemmli sample buffer and
subjected to SDS-PAGE (10% linear-gel) and immunoblotting
analysis using nitrocellulosemembranes (GE Healthcare Japan,
Tokyo, Japan) and the following primary antibodies: Rabbit
polyclonal anti-collagen type I antibody (1:1000) (Abcam),
Rabbit polyclonal anti-collagen type II antibody (1:1000)
(Abcam), Rabbit polyclonal anti-Sox9 (1:500) (Abcam), Rabbit
polyclonal anti-Runx2 (1:1000) (Santa Cruz), or Goat polyclonal
anti-actin antibody (1:2000) (Santa Cruz). Probed blots were
then treated with horseradish (HRP)-conjugated anti-rabbit
IgG (1:5000) (Santa Cruz) or HRP-conjugated anti-goat IgG
antibody (1:5000) (Santa Cruz), visualized with the ECL Plus
system (GEHealthcare Japan), and photographedwith a cooled
CCD-equipped Light Capture (Atto, Tokyo, Japan). Densito-
metric analysis was performed using TotalLab TL100 (TotalLab
Ltd., Newcastle upon Tyne, United Kingdom).
For reprobing with different primary antibodies, blots
were stripped with Restore PLUS Western Blot Stripping
Buffer (Thermo Fisher Scientific K.K., Yokohama, Japan).
cDNA synthesis and quantitative real time
polymerase chain reaction (QR-PCR)
Periosteal sheets cultured in plastic multi-well plates were
treated with RNAprotect (Qiagen, Germantown, MD) and total
RNA was extracted using an RNeasy mini purification kit
(Qiagen), as described previously (Kawase et al., 2011). Total
RNA was then reverse transcribed using the SuperScript VILO™
cDNA Synthesis Kit (Invitrogen) according to the manufacturer's
instructions. QR-PCR was performed using a Smart Cycler
system (Cepheid, Sunnyvale, CA). Real-time monitoring of the
following genes was performed using TaqMan probes using
the manufacturer's standard protocol (TaqMan Gene Expres-
sion Assays and TaqMan Universal PCR Master Mix; Applied
Biosystems, Carlsbad, CA): TGF-β1 (TGFB1, Hs00998133_m1),
CTGF (CTGF, Hs00170014_m1), Collagen, type I, alpha 1
(COL1A1, Hs01076775_g1), IL-6 (IL6, Hs00985641_m1),
αSMA (ACTA2, Hs00426835_g1), Integrin, alphav (ITGAV,
Hs00233790_m1), Integrin, beta3 (ITGB3, Hs00173978-m1),
Collagen, type II, alpha 1 (COL2A1, Hs00264051_m1),
and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
Hs99999905_m1).
Procedures for αSMA fiber formation and functional
assay of tension development
As described for the periosteal sheets cultured in plastic
dishes, periosteum tissue segments were directly placed on
collagen mesh (Integran®) and expanded with MesenPRO or
the control Medium 199 medium for up to 24 days. The
periosteal sheet-mesh complexes were then photographed.
When tensile force was developed, the collagen mesh was
bent.
Periosteal sheet-derived cells, which were dispersed
from periosteal sheets and passaged once or twice, were
seeded at a high or low density onto glass coverslips andincubated in the control medium in a CO2 incubator for 6 h.
For the inhibition of de novo protein synthesis, cells were
treated with 1 mM cycloheximide (Wako Pure Chemicals,
Okasa, Japan) for 24 h prior to inoculation. At the end of
incubation, the cells were fixed and subjected to the
immunofluorescence staining for αSMA.
Flow-cytometric (FCM) analyses
Cells were dispersed from cultured periosteal sheets with
0.05% trypsin+0.53 mM EDTA solution (Invitrogen), washed
twice in PBS, and suspended in 0.1 mL of PBS at a density of
1×106cells/mL. The cells were then probed for 40 min at
4 °C with 10–20 μL of mouse monoclonal antibodies for cell
surface antigens: anti-CD73-PE (IgG1) (Myltenyi Biotech
GmBH, Bergisch Gladbach, Germany), anti-CD90-FITC (IgG1)
(Myltenyi), anti-CD105-FITC (IgG2a) (Myltenyi), anti-CD11b-
FITC (IgG2b) (Abcam), anti- CD19-FITC (IgG1) (Abcam), anti-
CD34-FITC (IgG1) (Abcam), anti-CD45-FITC (IgG1) (Abcam),
anti-HLA-DR-FITC (IgG2a) (Abcam), anti-CD39-FITC (IgG1)
(Abcam), anti-CD51/61-FITC (IgG1) (Abcam), anti-CD44-FITC
(IgG1) (BioLegend, San Diego, CA), anti-CD106-PE (IgG2a)
(BioLegend), anti-CD146-PE (IgG2a) (BioLegend), and anti-
STRO-1 (IgM) (Santa Cruz). After being washed twice with
PBS, the cells were analyzed by flow cytometry (Cell Lab
Quanta; Beckman Coulter, Miami, FL). The cells that were
probed with anti-STRO-1 were additionally probed with
Alexa Fluor® 546-conjugated goat anti-mouse IgM (1:100)
(Invitrogen), washed, and then analyzed. The data analysis
and histogram overlay were performed using FlowJo software
(Tree Star, Inc., Ashland, OR). For isotype controls, individual
corresponding antibodies (all from Miltenyi) were used.
Animal implantation study
Balb/c-nu/numice (male, age: 5-weeks-old, weight: 15–20 g)
were obtained from Charles River Laboratories (Yokohama,
Japan) and housed at the Brain Research Institute Center for
Bioresource-based Research, Niigata University, at least one
week prior to the experiment.
Periosteal sheets were rinsed three times with PBS,
harvested with a cell scraper, and implanted into the sub-
cutaneous tissue of nude mice. Surgical procedures were
aseptically performed under standard conditions, as described
previously (Kawase et al., 2012a). The care and use of animals
followed the Guiding Principles for the Care and Use of
Animals, as approved by Niigata University.
Micro-computed tomography
To evaluate the volume of mineral deposits formed in
cultured and implanted periosteal sheets, micro-computed
tomographic (μCT) imaging was performed using a μCT
imaging scanner (SMX-100CT; Shimadzu, Kyoto, Japan) as
described previously (Kawase et al., 2009). The X-ray tube
voltage, current and slice thickness in this study were
58 kV, 58 μA and 1.1×10–2 mm. The field of view size was
4.24 mm with a 512×512 matrix; therefore, each pixel size
was 8.3×10–3 mm. The spatial resolution of the μCT
imaging scanner was previously demonstrated using porous
hydroxyapatite cylinders (Nakayama et al., 2011b). These
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ware (VGStudio Max2; Volume Graphics GmbH, Heidelberg,
Germany).
Cell labeling and in vivo NIR imaging
Whole attached cultured periosteal sheets were labeled
with CellVue® NIR815 dye (Molecular Targeting Tech-
nologies, Inc., West Chester, PA) in accordance with the
manufacturer's instruction. In brief, adherent periosteal
sheets were washed twice with Hank's balanced salt
solution (HBSS) (Invitrogen) and treated for 5 min at room
temperature with the dye diluted in Diluent C (Molecular
Targeting Technologies) at the final concentration of 2 μM.
The periosteal sheets were then rinsed twice with HBSS and
incubated in the individual culture media in a CO2 incubator
until implantation (~1 h). The animal implantation was
performed as described in the Animal implantation study
section.
Living implanted nude mice, which had been fed a
chlorophyll-free diet (Research Diets, Inc., New Brunswick,
NJ), were maintained by isoflurane inhalation anaesthesia
on an animal stage warmed to 37 °C during the in vivo
imaging process as described previously (Nakayama et al.,
2011a). The in vivo NIR imaging was performed as described
in the Optical analysis of the periosteal sheet's thickness by
near-infrared (NIR) imaging section section.
At the end of all imaging, implanted periosteal sheets
were retrieved with surrounding tissue from mice sacrificed
by an over-dose of pentobarbital (Nembutal; DS Pharma),
weighed, and serially subjected to ex vivo imaging, μCT
analysis and histological examination.
Statistical analysis
The statistical significance of differences between the groups
was analyzed by a Student's t-test or a one-way analysis of
variance (ANOVA). Comparisons between individual groups
were determined using Tukey's multiple comparison test.
P valuesb0.05 were considered significant.
Results
The growth of periosteal sheets
In MesenPRO medium, periosteal sheets became thick
enough to be visible to the naked eye (Fig. 1A; indicated
by arrows), but in the control medium (Medium 199
supplemented with 10% FBS), periosteal sheets did not
grow thick (Fig. 1B, the peripheral outline of the sheet is
shown by the dashed line). The increased thickness must
have been caused by an increased number of cells and/or
increased deposition of extracellular matrices (ECMs);
perhaps both factors contributed to the macroscopic effect.
In terms of the diameter of the periosteal sheet, which
mainly represents the two-dimensional expansion of cells,
no significant differences were observed between MesenPRO
and the control medium (Fig. 1C). In contrast, the DNA
content of periosteal sheets expanded with MesenPRO was
approximately 4-fold higher than when expanded with thecontrol medium (Pb0.001) (Fig. 1D); this implies that there
was a much higher number of cells in the MesenPRO cultures.
The difference in thickness could be more precisely and
quantitatively demonstrated by NIR imaging technology; the
binding of an RGD probe was strongly increased in periosteal
sheets cultured in MesenPRO medium (Figs. 1E–G). The FI
value of sheets expanded with MesenPRO was 216.0, while
those expanded with the control medium was either 58.5
(basal, non-induced) or 37.1 (osteoinduced). The optical NIR
imaging was performed based on the finding that integrin αv
and β3 mRNAs were not differentially expressed between
periosteal sheets expanded with MesenPRO and those
expanded with control medium (Figs. 1H,I). Therefore, this
finding suggested that the optical density of bound RGD
probe would accurately quantitate the thickness of the
multiple cell layers. Similar findings, although less dynamic
in their range, were obtained from macroscopic observa-
tions of individual periosteal sheets that were then fixed
and stained with Safranin O (used here as a nuclear stain,
Fig. S1).
Therefore, we postulated that this difference might in
part be reflected by a difference in the densities of
the proliferating cells found in the proximal regions of
explanted cell-multilayers, the area that immediately
borders the region of the original periosteal tissue segment.
Indeed, there was a significant difference (MesenPRON the
control medium) between the densities of PCNA-positive cells
in this region of the two treatment groups (Pb0.05) (Figs. 1J
vs. K; L).Collagen deposition and osteoblastic differentiation
in periosteal sheets
When sagittal sections of the periosteal sheets were ex-
amined microscopically, it was immediately evident that the
periosteal sheet expanded with MesenPRO was thicker than
that expanded with control medium. This was particularly
noticeable in the region surrounding the original seeded
segments of periosteal tissue (Figs. 2A vs. B). The cell
multilayers in the MesenPRO group were evaluated to be
more than 10 layers thick; with an approximately 250–
300 μm thickness in the proximal regions of explanted cell
layers observed in the paraffin sections. In these cell
multilayers, the extracellular spaces were relatively wide
and open and were utilized for what appeared to be
abundant collagen deposition (Fig. 2C). In contrast, the
multilayers formed by outgrown cells in control growth
medium, were composed of approximately 2–3 layers (only
10–20 μm in thickness) in similar regions, and the open
extracellular spaces were limited and narrow (Fig. 2D).
Immunofluorescence staining of collagen type I demonstrated
that the major collagen type produced in both periosteal-
sheet cultures was type I and this collagen type I protein was
preferentially deposited on the basal side versus the apical
side of periosteal sheets expanded with MesenPRO (Figs. 2E,G,
I). In contrast, collagen type I deposition in the thin explanted
region of periosteal sheets expanded with the control medium
was distributed much more uniformly from the top to bottom
of the sheet (Figs. 2F,H,J).
Collagen synthesis was then evaluated by several bio-
chemical methods. The amount of collagen released into the
Figure 1 Effects of MesenPRO medium on the growth of periosteal sheets. (A, B) Macroscopic observations of the thickness of
periosteal sheets expanded for 24 days with MesenPRO medium (A) or the control medium (B). Bar=10 mm. (C) The diameters of
periosteal sheets cultured for 24 days. n=3. (D) The DNA contents of periosteal sheets cultured for 24 days. n=4. (E–G) Optical NIR
imaging of the thickness of living periosteal sheets using IRDye® 800CW-RDG. The periosteal sheets were expanded for 24 days with
MesenPRO (E) or the control medium (F). In the osteoinduction cultures, periosteal sheets expanded with the control medium were
treated with the osteogenic inducing agents for the last 6 days (G). Bar=10 mm. (H, I) Time-course for the mRNA of integrin αv
(H) and β3 (I) receptors for the RDG peptide in periosteal sheets cultured in MesenPRO (closed circles) or the control medium (open
circles). n=3. (J, K) Immunohistochemical observations for PCNA-positive cells in periosteal sheets expanded with MesenPRO (J) or
the control medium (K) for 24 days. The asterisks represent the original periosteum tissue segments. Bar=50 μm. (L) Numbers of
PCNA-positive cells in the views of cell multilayers adjacent to the original periosteum tissue segments. The data was expressed by
the ratio (%) of PCNA-positive cells to total cells detected in this region. n=4.
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Figure 1 (continued).
7Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)culture medium reflects the initial cellular biosynthesis and
release of collagen by cells in a monolayer culture, this
parameter wasmeasured first in the explant cultures. Although
the cells expanded more effectively with MesenPRO than with
the control medium, the established dye-based assay demon-
strated that the amount of collagen released over 24 h from
periosteal sheets expanded with MesenPRO, as normalized
against cellular DNA content, was significantly lower than the
amount measured in the medium of the control cultures
containing 2% (v/v) FBS (equivalent to the FBS component of
MesenPRO) (Pb0.005) (Fig. 3A). However, as assessed by
qRT-PCR analyses, the mRNA expression of collagen type I
(normalized against GAPDH) was not significantly different in
MesenPRO expanded cultures (Fig. 3B) as compared with the
control. Western blotting analysis of protein extracts from the
expanded region of periosteal sheets, from sheets in which
the original seeded segment of periosteal tissue had been
removed, demonstrated that substantially higher levels of
collagen type I were deposited into the periosteal sheets
expanded with MesenPRO than those expanded with the
control medium (Fig. 3C). These findings imply that
elaborated collagen was more efficiently incorporated
into the matrix of MesenPRO expanded sheets, compared
with the control periosteal sheet, in which large extracel-
lular spaces had formed within the thicker, cell multilay-
ered structure.
Unexpectedly, the expression level of the Runx2 protein,
a representative transcription factor for the early stages of
osteoblastic differentiation, was substantially higher in
periosteal sheets expanded with control medium than in
the periosteal sheets expanded with MesenPRO (Fig. 3D).
Collagen type II protein was faintly detected only in the ECM
from periosteal sheets expanded with MesenPRO (Fig. 3E),
but the expression of collagen type II mRNA was not
detected in samples from either type of periosteal sheet
(data not shown). The Sox9 protein, a representativetranscription factor for chondrocytes, was barely detectable
in either type of periosteal sheet (Fig. 3F).
The possible chondrocytic differentiation of cells con-
tained in periosteal sheets expanded with MesenPRO was
excluded by both immunohistochemical and histological
examinations. Alcian blue stained ECM in both cell multi-
layers similarly (Fig. S2A vs. B), whereas Safranin O stained
the cell multilayers of periosteal sheets expanded with the
control medium more intensively than those expanded with
MesenPRO (Fig. S2C vs. D). However, it should be noted that
most of the structures stained by Safranin O were cell nuclei
rather than ECM proteins. Therefore, these data can be
interpreted as confirming the higher cell density, and smaller
extracellular spaces of periosteal sheets expanded with the
control medium. Toluidine blue always produced intensive
staining of the cell nuclei, but did not stain the ECM proteins
very well in the periosteal sheets prepared in either type of
medium (Fig. S2E vs. F).
Detailed immunofluorescent examination confirmed that
detectable levels of collagen type II were not deposited in
the extracellular spaces of either type of periosteal sheet
(Fig. S3). Similarly, Sox9 was not detected in either type of
periosteal sheet (Fig. S4). Positive and negative controls
were prepared from bone and cartilage tissues of rats and
stained by the same protocols with which the periosteal
sheets were examined (Fig. S5).Generation of contractile force and formation of
αSMA fibers
A detailed immunofluorescence study using an anti-αSMA
antibody demonstrated that intense fluorescence signals
were observed on and just below the surface areas of both
the bottom side and the upper side of periosteal sheets
expanded with MesenPRO (indicated by arrows). However,
Figure 2 Histological and immunohistochemical observations of collagen deposition in periosteal sheets. The periosteal sheets
were expanded with MesenPRO medium (A, C, E, G, I) or the control medium (B, D, F, H, J) for 24 days. (A, B) HE-staining. The
asterisks represent the original periosteum tissue segments. Bar=250 μm. The regions indicated by rectangles were shown in the
following panels with higher magnifications. (C, D) Masson's trichrome staining. Bar=100 μm. (E–J) Immunohistochemical staining for
collage type I (E, F) and nuclear counterstaining with DAPI (G, H). These images were merged (I, J). Bar=50 μm.
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Figure 3 Biochemical analyses of collagen production and mRNA expression of transcription factors related to osteoblastic or
chondrocytic phenotypes. (A) Colorimetric analysis for collagen released into culture media for an additional 24 h in periosteal sheets
expanded for 24 days. n=4. (B) Quantitative RT-PCR analyses for the expression of collagen type I mRNAs in periosteal sheets
expanded for 24 days. The data were normalized by GAPDH. n=5. Note: Collagen type II mRNA was not determined due to lower,
undetectable levels. (C, D, E, F) Western blotting analyses for the expression of marker proteins related to osteoblastic or
chondrocytic differentiation. Periosteal sheets that were expanded for 24 days were extracted and subjected to Western blotting
analyses for collagen type I (C), Runx2 (D), collagen type II (E), and Sox9 (F). The densitometric data were normalized by actin.
Similar data were obtained from two additional independent sets of samples.
9Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)αSMA was not detected in periosteal sheets expanded with
the control medium (Figs. 4A vs. B).
To address the question regarding why αSMA fibers were
formed in the surface regions of periosteal sheets cultured in
MesenPRO medium, the contractile force in periosteal sheets
cultured on collagenmesh scaffolds was examined (Figs. 4C–E).
In culture, periosteal sheets expandedwithMesenPRO gradually
becamedistorted over time (Figs. 4C vs.D: 18 days vs. 24 days),
while there was no distortion observed in the control periosteal
sheets (Fig. 4E). As shown by histology (Figs. 4F,G), periosteal
sheets expanded with MesenPRO developed many proliferating
cells that penetrated three-dimensionally into the deep regions
of the collagen scaffold, while cells only expanded two-
dimensionally into the surface regions of the scaffold grown
when with the control medium.
This structural difference, the development of a thicker,
more multilayered expanded region, may be the cause of
the difference in the generation of contractile force in the
periosteal sheets. Dispersed periosteal cells cultured on
glass coverslips were examined to determine the relation-
ship between cell-cell contact and αSMA fiber formation.
When cells were inoculated at higher cell densities, some
cells overlapped each other; the overlapping contactappeared to trigger the αSMA fiber formation within 6 h
(Fig. 4H). This time interval is too short to produce sig-
nificant levels of αSMA protein through an increase in gene
expression. In contrast, when cells were seeded at low
densities, although αSMA-reactive proteins were distributed
diffusely in the cytoplasm, αSMA fibers were not observed
(Fig. 4I). To further confirm that de novo synthesis of αSMA
protein was not involved in the fiber formation, we pretreated
periosteal cells with cycloheximide (1 mM) for 24 h and then
seeded trypsinized cells at a low or high density. As seen
previously, cells seeded at a high density overlapped one
another and formed αSMA fibers in the cytoplasm within 6 h
(Figs. 4J vs. K). Cell–cell interaction appears to be the
determining factor for the αSMA fiber formation.
To more thoroughly examine the mechanism of αSMA
fiber formation in periosteal sheets, the expression of
several specific factors, which are thought to promote
myofibroblastic differentiation and cause the upregulation
of αSMA (Hinz et al., 2007), were evaluated at the level of
mRNA expression. As an appropriate comparison, periosteal
sheets receiving osteoinduction were compared to other
periosteal sheets. Surprisingly, the relationships we had
predicted were not observed; TGF-β1 mRNA was significantly
10 K. Uematsu et al.down-regulated by MesenPRO medium (Pb0.002) (Fig. 4L).
Neither CTGF nor αSMA mRNA was significantly influenced by
culturemedia (Fig. 4M,N). In agreement with previous reports
that analyzed the supernatants from cultures of periostealsheets (Kawase et al., 2009), IL-6, a potent regulator of αSMA
(Hinz, 2007), was significantly down-regulated by MesenPRO
medium (Pb0.005) (Fig. 4O). This cytokine was also down-
regulated by in vitro osteogenic induction (Pb0.02).
Figure 4 Formation of αSMA fibers, generation of contractile force, and gene expression related to myofibroblastic differentiation in
periosteal sheets. (A, B) Immunohistochemical observations for αSMA (green: indicated by arrows) in sagittal sections of periosteal sheets
expanded for 24 days with MesenPRO (A) or the control medium (B). Nuclear staining with DAPI (blue). Bar=100 μm. (C–E) Appearances
of collagen mesh scaffolds for periosteal-sheet cultures. Periosteal sheets expanded with MesenPRO medium for 18 days (C) or 24 days
(D), or with the control medium for 24 days (E). Bar=5 mm. (F, G) Cell invasion into collagen mesh scaffolds from periosteal sheets
expanded for 24 days with MesenPRO (F) or the control medium (G). Dashed lines represent the front lines of cell invasion. Bar=250 μm.
(H–K) Effects of cell density on the formation of αSMA fibers in cells dispersed from non-pretreated (H, I) or cycloheximide-pretreated
cultures (J, K). Cells at high (H, J) and low cell densities (I, K) on coverslips and incubated for 6 h. Bar=20 μm. (L–O) Expression of mRNAs
related to myofibroblastic differentiation in periosteal sheets. Periosteal sheets expanded for 24 days with MesenPRO or the control
medium. In the osteoinduction cultures, periosteal sheets expanded with the control medium were treated with the osteogenic inducing
agents for the last 6 days. Extracted mRNA was subjected to qRT-PCR for TGF-β1 (L), CTGF (M), αSMA (N), or IL-6 (O). n=4.
11Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)Further characterization of
osteoblastic differentiation
The data presented to this point do not support the possible
differentiation towards osteoblast, chondrocyte, or
myofibroblast. Thus, additional characterization of surface
antigens was performed to evaluate how efficiently poten-
tial immature and/or committed progenitor cells, often
referred to in the literature as “mesenchymal stem cells,”
could have been expanded by the MesenPRO medium.
Detailed FCM analysis coupled with cytochemical staining
for ALP activity was used to examine cells dispersed from
periosteal sheets by mild trypsinization. According to the
minimum criteria developed for identifying stem cells
(Dominici et al., 2006), a number of positive markers,
including CD73, CD90, and CD105, were examined. All of
these surface antigens were highly expressed in cells derived
from periosteal sheets expanded with the control medium.
Unexpectedly, CD73 and CD105, but not CD90, were sub-
stantially downregulated by expansion with MesenPRO
(Figs. 5A–C). In contrast, CD146 was substantially upregulated
by MesenPRO (Fig. 5D). CD44 was highly expressed, but this
was not influenced by either medium (Fig. 5E). Surprisingly,
the percentage of STRO-1-positive cells was less than 2% in
either type of periosteal sheet (Fig. 5F). Among the negative
markers (CD45, D34, CD11b, CD19, HLA-DR) suggested by theposition paper (Dominici et al., 2006), no appreciable changes
were observed (Fig. S6A–E). As for other major markers
(CD39, CD106, CD51/61) that have been widely examined
elsewhere, the cells were found to be negative for both CD39
and CD106 (Fig. S6F,G). CD51/61, also known as integrin αvβ3
(see Figs. 1E–I), was confirmed to be expressed at appreciable
levels in cells of periosteal sheets, but this expression was not
influenced by the culture media (Fig. S6H). The quantitative
data derived from these extensive analyses are summarized in
Table 1.
The ALP activity expressed in periosteal sheets expanded
with MesenPRO was consistently maintained at levels lower
than normally observed in periosteal sheets expanded with the
control medium; this level was not appreciably upregulated by
in vitro osteogenic induction (Figs.6A vs. B). As previously
observed (Kawase et al., 2009), the ALP activity of control
periosteal sheets increased spontaneously during expansion,
and as would be expected, it was strongly upregulated by
osteogenic induction (Figs. 6C vs. D). Similar findings were
obtained from μCT examination. Relatively few mineral de-
posits were detected in the regions of the original periosteum
tissue segments of periosteal sheets expanded with MesenPRO
(Figs. 6E,G), while notable mineral deposits were formed in the
regions of the original periosteum tissue segments of the control
periosteal sheets, even though the control sheets had not yet
received the osteogenic induction (Figs. 6F,H). The estimated
Figure 5 Flow-cytometric analyses of cell surface antigens expressed in periosteal sheets cultured in the MesenPRO medium. Periosteal
sheets expandedwith MesenPRO or the control medium for 20–30 days were trypsinized and subjected to flow-cytometric analyses of CD73
(A), CD90 (B), CD105 (C), CD146 (D), CD44 (E), and STRO-1 (F). Red line: Isotype control (periosteal sheets cultured in controlmedium). Blue
line: Periosteal sheets cultured in MesenPRO medium. Orange line: Periosteal sheets cultured in the control medium.
12 K. Uematsu et al.volume of these mineral deposits was significantly higher
than that of mineral deposits formed within MesenPRO-
expanded sheets (Fig. 6I). Thus, prior to implantation,
MesenPRO-expanded periosteal sheets showed weaker osteo-
genic properties than did the control periosteal sheets.Animal implantation study
The results of the findings from detailed FCM analysis did
demonstrate that immature CD146-positive cells, incom-
pletely characterized in the literature as cells that can
sometimes be induced to become osteoblastic, are present
in increased numbers within periosteal sheets expanded
with MesenPRO. However, the downregulation of ALP in
vitro clearly suggested a decreased osteogenic capacity for
the MesenPRO expanded sheets. To settle this puzzling
finding and to determine the in vivo performance of each
periosteal sheet, it was necessary to implant both types of
sheet into the backs of nude mice.
At 8 weeks post-implantation, the original periosteal tissue
segments and expanded regions within both types of perios-
teal sheet were clearly identified in tissues retrieved from the
implantation site and then stained with HE (Figs. 7A,B). The
cells included in the regions corresponding to the originalsegments of periosteum, regardless of the culture media used
prior to implantation, were morphologically identified as a
cuboidal, osteocyte-like shape, as shown in the higher
magnification photomicrographs (Figs. 7C,D). The cells in the
regions were further characterized by immunohistochemical
methods. CD146-positive cells were enriched within the
MesenPRO-expanded periosteal sheets in vitro, and this
characteristic was maintained in vivo after implantation
(Figs. 7E vs. F). In similar regions, human Ki67-positive cells
were detected both within the MesenPRO-expanded and the
control periosteal sheets (Figs. 7G vs. H). Although neither
Runx2 nor ALP was normally detected in the MesenPRO-
expanded periosteal sheets in vitro, both of these osteoblastic
marker proteins were substantially upregulated after implan-
tation (Figs. 7; I vs. J; K vs. L). In the non-immune control, no
immune-reactive target proteins were detected (Fig. S7).
The levels of mineral deposit formation in the two types of
periosteal sheet were again examined with a μCT scanner after
implantation. Although only rarely observed in MesenPRO-
expanded periosteal sheets in vitro, mineral deposits were
very actively formed after implantation, while the mineral
deposits formed in the control periosteal sheets in vitro were
not appreciably increased after implantation (Figs. 8A vs. B).
This increased osteogenic activity in the implanted MesenPRO-
expanded sheets parallels the increased in vivo expression of
Table 1 The effects of MesenPRO medium on the expression of cell surface antigens in cultured periosteal sheets.
Antigens Mean FL Positive cells (%)
MesenPRO Medium 199 MesenPRO Medium 199
Positive markers
CD73 876.0±349.0 b (n=6) 2422.1±696.6 (n=8) 96.5±3.1 a (n=8) 99.5±0.5 (n=6)
CD90 730.7±288.3 (n=6) 657.3±127.0 (n=8) 97.5±3.0 (n=6) 96.7±3.6 (n=8)
CD105 31.2±18.4 b (n=6) 98.0±27.4 (n=8) 67.8±9.4 b (n=6) 98.1±1.4 (n=8)
Negative markers
CD45 15.2±5.0 (n=7) 24.2±18.2 (n=5) 3.1±1.4 (n=7) 2.4±0.4 (n=5)
CD34 16.2±9.1 (n=8) 18.7±6.4 (n=7) 1.9±1.1 (n=8) 5.2±4.5 (n=7)
CD11b 8.1±5.9 (n=4) 9.0±4.9 (n=4) 0.2±0.2 (n=4) 0.5±0.6 (n=4)
CD19 13.1±5.3 (n=3) 9.5±1.1 (n=3) 0.5±0.1 (n=3) 1.1±0.3 (n=3)
HLA-DR 4.3±4.9 (n=3) 6.4±3.9 (n=3) 0.2±0.3 (n=3) 0.9±0.8 (n=3)
Other markers
CD39 6.5±3.4 (n=5) 7.3±2.5 (n=5) 4.4±1.5 (n=5) 4.5±2.1 (n=5)
CD44 472.0±197.5 (n=3) 706.7±201.6 (n=3) 99.0±1.0 (n=3) 99.8±0.1 (n=3)
STRO-1 24.1±14.7 (n=3) 17.5±5.8 (n=4) 1.2±0.1 (n=3) 2.5±2.2 (n=4)
CD146 60.2±19.6 b (n=6) 15.7±9.0 (n=6) 55.4±17.4 b (n=6) 20.0±6.2 (n=6)
CD106 6.8±3.7 (n=5) 10.1±2.2 (n=5) 5.7±3.7 (n=5) 8.8±5.3 (n=5)
CD51/61 8.3±5.1 (n=4) 7.3±4.6 (n=4) 15.1±12.2 (n=4) 12.4±5.6 (n=4)
a Pb0.05 compared to the control medium (Medium 199 supplemented with 10% FBS).
b Pb0.001 compared to the control medium (Medium 199 supplemented with 10% FBS).
13Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)Runx2 and ALP. Three-dimensional reconstruction of μCT slice
images revealed that the volumes of mineral deposits formed
by both types of periosteal sheet were almost equal (Figs. 8C
vs. D). No statistical difference was observed between these
two types of periosteal sheets (Fig. 8E).
To support the findings for human Ki67-positive cells and to
reconfirm the survival and growth of cells derived from
periosteal sheets after implantation, cells were labeled with
an NIR dye prior to implantation and tracked by the in vivo NIR
imaging technique after implantation. Although the fluorescent
intensity changed over time for various reasons (e.g., normal
attenuation of the dye, the depth below the skin surface, the
orientation of the animal relative to the scanner, the daily
condition of the NIR Imager), the fluorescent signals were
clearly detected for 4 weeks after implantation (Fig. S8).
Discussion
Formation of a thick multilayer of cells and
expansion of the CD146-positive cells
The periosteum has two distinguishable layers: an outer
fibrous layer and an inner juxtaosseal cambium layer (Ito et
al., 2001). Osteoblasts, along with other cells that include
osteochondral precursor cells and fibroblasts (Youn et al.,
2005), are found within the cambium layer, while the fibrous
layer is composed of fibroblastic cells enmeshed in a
collagen and elastin fiber matrix containing an extensive
nerve and microvascular network (Ellender, 1988). When
segments of alveolar periosteum are harvested in clinical
practice, protocol limitations make it difficult to obtain
intact full-thickness periosteal tissue segments (Kawase,2010). As a result, we generally must use the fibrous layer to
prepare in culture an “osteogenic grafting material” for
clinical use.
The original purpose of this study was to test the ability of a
stem-cell medium to produce a more potent grafting material
by expanding the population of immature, noncommitted
progenitor cells and/or osteogenic progenitor cells that are
thought to be part of cultured periosteal sheets. In a previous
series of studies (Kawase et al., 2009, 2010a, 2010b), we
demonstrated that explant culture of periosteal tissue seg-
ments produces periosteal sheets that can be subjected to in
vitro osteogenic induction to differentiate some constituents
of the cell-multilayers into ALP-positive cells that are capable
of formingmineral deposits in vitro and bone-like tissue in vivo.
Certain observations had suggested to us that the source of
these osteoblastic cells was a resident population of immature
osteogenic progenitor cells that had originated from within the
harvested periosteal segment.
MesenPRO medium proved to be the most effective for
expansion of cells in our periosteal-sheet cultures. Perios-
teal sheets expanded with MesenPRO were clearly distin-
guishable from the periosteal sheets expanded with the
control medium, especially in terms of thickness. We found
that the increased thickness resulted from an increase in the
number of cells and in collagen deposition. Interestingly,
periosteal sheets expanded with MesenPRO were composed
largely of cells that expressed CD146 (approximately 55% of all
cells, a 3-fold increase over control periosteal sheets in the
particular regions). In addition, FCM analyses indicate that
MesenPRO clearly expanded the numbers of CD146-positive
cells within periosteal sheets and increased the expression of
CD146. Because CD146 is a known adhesion molecule
(Guezguez et al., 2007), it is likely that the large increase in
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15Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)the numbers of CD146-positive cells contributed to the
reorganization of the 3D multilayered structure of cells within
the thick explanted parts of the periosteal sheets.
More importantly, it was recently reported that CD146-
expressing bonemarrow stromal cells, commonly identified as
pericytes, function to induce bone formation and organize the
hematopoietic microenvironment (Sacchetti et al., 2007).
Coincidently, we previously observed that periosteal sheets
are formed largely from cells that proliferate rapidly and
migrate out from around the walls of the capillaries contained
within the original periosteal tissue segment (Kawase, 2010;
Kawase et al., in press). Therefore, because periosteum, like
bone marrow, is very closely related to bone, we suggest that
an expanded population of CD146-positive cells similar to
the pericytes from bone marrow stroma may result in the
enhanced osteogenic potential of the periosteal sheets.
Our animal implantation experiment has provided evidence
to support the enhanced osteogenic nature of these MesenPRO-
expanded periosteal sheets in vivo. Although standard in vitro
osteogenic induction failed to produce significant numbers of
ALP-expressing osteoblastic cells prior to implantation, perios-
teal sheets expanded with MesenPRO demonstrated much
greater osteogenic capacity in vivo through the upregulation
of Runx2, ALP, and formation of mineral deposits. Therefore,
although cells contained in the MesenPRO-expanded periosteal
sheets were much less osteogenic at the time of implantation,
it is noteworthy that these periosteal sheets became strongly
osteogenic after implantation. The enhanced osteogenic
capacity of the MesenPRO-expanded periosteal sheets may
be explained by two possible independent pathways. First,
CD146-positive and/or other progenitor cells, whose differen-
tiation has been suppressed in vitro, differentiate into
osteoblastic cells in vivo as a result of being removed from
the MesenPRO medium. Additionally, because the periosteal
sheets have been shown to release various growth factors,
some ofwhich are closely related to bonemetabolism (Kawase
et al., 2009), it is also possible that implanted periosteal
sheets may influence the recipient and effect the recruitment
of progenitor cells from the surrounding tissue and circulation
to become osteoblasts and/or osteoclasts. Therefore, we
speculate that these two independent pathways may
cooperate more fully to promote the ectopic bone-like
tissue formation associated with the MesenPRO-expanded
periosteal sheets.Myofibroblastic differentiation does not
appear significant
It has recently been suggested that CD45, CD34, vimentin, and
αSMA are included in the set of markers unique to the fibrocyte
and are involved in intimal hyperplasia (Varcoe et al., 2006).
Fibrocytes are initially recruited from circulating precursorFigure 6 ALP activity and mineral deposit formation in cultured pe
ALP activity in periosteal sheets expanded with MesenPRO. Periostea
control medium (C, D). For osteogenic induction, periosteal sheets w
6 days in the same media (B, D). Bar=10 mm. (E–H) μCT observations
sheets were expanded for 38 days with MesenPRO (E, G) or the contro
(G, H) images are shown. Bar=0.5 mm. (I) Volume of mineral depositscells by injured tissue, where they are induced by TGF-β1 to
become fibroblasts and then consequently develop into
myofibroblasts that express abundant αSMA stress fibers and
develop contractile force to repair tissue injury (Bellini and
Mattoli, 2007). CTGF is thought to be a component mediating
and amplifying the TGF-β1 signal for collagen synthesis (Hinz et
al., 2007).
Gong et al. (2009) used an ELISA system to demonstrate
that the MesenPRO medium supplemented with 2% FBS
contained very low levels of exogenous TGF-β1 (an impor-
tant finding because the vendor does not disclose all the
ingredients in MesenPRO). In periosteal-sheet cultures grown
in MesenPRO medium, where neither endogenous TGF-β nor
CTGF were upregulated and the expression of collagen-I
remained largely unchanged, αSMA fibers were still formed
to generate contractile force. Notably, our experiments
using dispersed periosteal sheet-derived cells demonstrate
that cell-cell contact rapidly induced the formation of αSMA
fibers without de novo production of endogenous αSMA.
In this case, it is possible that cells in small regions of the
periosteal sheet could polymerize the αSMA monomer
gradually over time in order to maintain and reinforce αSMA
fibers in a manner independent of the autocrine/paracrine
systems mediating myofibroblastic differentiation (described
above). Under similar conditions, it has been reported that
fibroblasts can attach to and migrate in 3D collagen lattices
while generating contractile force without evidence of
myofibroblastic differentiation (Brown et al., 2002). If the
known autocrine/paracrine system functions within periosteal
sheets, then we would expect that αSMA should be expressed
much more widely than what is observed. Therefore, we
believe that the observed contractile force could be generat-
ed by immature and/or osteogenic progenitor cells that are
migrating and producing 3D collagen lattices inside the
cell-multilayers of the periosteal sheets.Chondrocytic differentiation is not evident
When the process of skeletogenesis or the repair of a long bone
fracture is considered, osteoblast differentiation and matura-
tion lead to bone formation by both intramembranous and
enchondral ossification, and these processes start from con-
densed “mesenchymal precursors” (Day et al., 2005). However,
inmaxillofacial skeletal tissue, it is widely understood that bone
fractures are repaired solely by intramembranous ossification
that does not include any initial synthesis of cartilage. The
observation that the formation of cell multilayers involved in
the development of the wide and open extracellular spaces
in MesenPRO-expanded periosteal sheets suggested that
there was a possibility that endochondral ossification was
stimulated during the formation. However, accepted chon-
drocytic markers, such as collagen type II and Sox9, wereriosteal sheets. (A–D) Negative effects of osteogenic induction on
l sheets were expanded for 24 days with MesenPRO (A, B) or the
ere treated with the osteogenic inducing agents for an additional
of mineral deposits formed in periosteal sheets in vitro. Periosteal
l medium (F, H). Representative slice (E, F) and 3D reconstructed
evaluated from the above acquired images. n=6.
16 K. Uematsu et al.not significantly upregulated at either the protein or mRNA
levels. In addition, there is no significant histological
evidence for increased deposition of proteoglycans or
glycosaminoglycans into the extracellular spaces of these
sheets. Therefore, we have excluded the possibility that
significant differentiation of the cells into chondroblasts or
chondrocytes occurs in periosteal sheets expanded with
MesenPRO.
These periosteal sheets are derived frommaxillary alveolar
bone, and it may not be possible to induce enchondral
development in this tissue. Alternatively, this phenomenon
could be explained by a recent finding indicating that canonical
Wnt/β-catenin signaling is predominant in cells contained in
periosteal sheets and prevents chondrocytic differentiation
(Day et al., 2005). This possibility should be further investigat-
ed in periosteal sheets prepared by our method, for it would be
interesting to know if periosteum from long bone will give rise
to a different set of differentiated/undifferentiated cells when
processed by the protocol explored in these studies.Possible differentiation toward unidentified lineages
There was a possibility that some cells contained in periosteal
sheets expanded with MesenPRO began to differentiate along
an unidentified pathway and then arrest before reaching
maturity (i.e., at very early stages of differentiation). If
CD146-positive cells derived from periosteum can function as
multipotent progenitor cells, as reported elsewhere (Crisan etFigure 7 Histological and immunohistochemical observations of p
expanded with MesenPRO medium (A, C, E, G, I, K) or the control medi
the backs of nude mice. At 8 weeks post-implantation, the implants
histological and immunohistochemical examinations. (A–D) HE-stainin
periosteal tissue segments. The regions indicated by rectangles were sho
(A, B), or 25 μm (C, D). (E, F) CD146 expression. (G, H) Human Ki67 exp
nude mice. (K, L) ALP expression. The nuclei were faintly counterstainal., 2009), we could not rule out this possibility in our
periosteal-sheet cultures with our present surface antigen
data. Further study is needed to address the question as to
whether these CD146-positive cells from within periosteal
sheet cultures are already committed to the osteoblastic
lineage or still remain immature enough to differentiate to be
adipocytes, neural cells, or other matured cell types.Conclusions
MesenPRO medium is not a “selective” medium that expands
only the immature and/or osteogenic progenitor cells believed
to reside within human alveolar periosteal tissue. However,
this medium did effectively expand the population of highly
proliferative, CD146-positive cells in periosteal sheets and
downregulated or suppressed ALP activity. The subsequent in
vivo animal implantation study has revealed the biomedical
significance of these in vitro data: The periosteal sheets gained
substantial osteogenic capacity because expanded populations
of immature cells were stimulated to express Runx2 and ALP
and to form mineral deposits after implantation. In light of
what Chai et al. (2012) have demonstrated for the mechanism
of ectopic bone formation by human osteoprogenitor cells, the
sum of our present findings suggests that expansion with
MesenPRO should increase the in vivo osteogenic potential of
periosteal sheets derived from maxillofacial tissue without
appreciably upregulating osteogenic phenotypes in vitro.
Therefore, the thick multi-layered periosteal sheets preparederiosteal sheets implanted in nude mice. Periosteal sheets were
um (B, D, F, H, J, L) for 24 days and implanted subcutaneously into
were retrieved along with surrounding tissues and subjected to
g. The asterisks indicate the regions corresponding to the original
wn in the following panels with highermagnifications. Bar=250 μm
ression. (I, J) Runx 2 expression in periosteal sheets implanted into
ed with hematoxylin (faint purple). Bar=50 μm.
Figure 7 (continued).
17Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™)by this method are a promising osteogenic grafting material for
bone regenerative therapy.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2012.08.006.
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Figure 8 μCT observations of mineral deposits formed in periosteal sheets in vivo. Periosteal sheets were expanded for 38 days
with MesenPRO (A, C) or the control medium (B, D) and implanted into nude mice. Representative slice (A, B) and 3D reconstructed
(C, D) images are shown. Bar=0.5 mm. (E) Volume of mineral deposits evaluated from the above acquired images. n=3.
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